Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics.

@article{Veeranarayanan2012SynergisticTO,
  title={Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics.},
  author={S. Veeranarayanan and A. C. Poulose and M. S. Mohamed and S. H. Varghese and Y. Nagaoka and Yasuhiko Yoshida and T. Maekawa and D. S. Kumar},
  journal={Small},
  year={2012},
  volume={8 22},
  pages={
          3476-89
        }
}
  • S. Veeranarayanan, A. C. Poulose, +5 authors D. S. Kumar
  • Published 2012
  • Medicine
  • Small
    • The targeting and therapeutic efficacy of dye- and dual-drug-loaded silica nanoparticles, functionalized with triple targeting ligands specific towards cancer and neoangiogenesis simultaneously, are discussed. This synergized, high-precision, multitarget concept culminates in an elevated uptake of nanoparticles by cancer and angiogenic cells with amplified proficiency, thereby imparting superior therapeutic efficacy against breast cancer cells and completely disabling the migration and… CONTINUE READING
    View on PubMed
    doi.org
    30 Citations
    Background Citations
    4
    Results Citations
    1

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    30 Citations
    Citation Type

    Citation Type

    A highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapy.
    • 9
    Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    • 26
    Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents.
    • 41
    • PDF
    Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
    • 480
    Multifunctional Cu2−xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453
    • 23
    • PDF
    A new targeting agent for the selective drug delivery of nanocarriers for treating neuroblastoma.
    • 25
    • PDF
    New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
    • 27
    Structurally distinct hybrid polymer/lipid nanoconstructs harboring a type-I ribotoxin as cellular imaging and glioblastoma-directed therapeutic vectors.
    • 11
    Studies on interaction potency model based on drug synergy and therapeutic potential of triple stimuli-responsive delivery of doxorubicin and 5-fluoro-2-deoxyuridine against lymphoma using disulfide-bridged cysteine over mesoporous silica nanoparticles.
    • 4
    Type 1 ribotoxin-curcin conjugated biogenic gold nanoparticles for a multimodal therapeutic approach towards brain cancer.
    • 36

    References

    SHOWING 1-10 OF 39 REFERENCES
    Nanotechnology-mediated targeting of tumor angiogenesis
    • 72
    • PDF
    Targeted imaging and therapy of brain cancer using theranostic nanoparticles.
    • 90
    Peptide-mediated cancer targeting of nanoconjugates.
    • 46
    Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis.
    • 129
    Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer
    • 82
    • PDF
    A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers.
    • 206
    Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer.
    • 233
    • PDF
    Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.
    • 315
    Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles.
    • 82
    Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.
    • 318